Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Poole

Showing results (231-240 of 302) with videos related to

Pageof 31
Sort By:
Journal of Cardiovascular Electrophysiology|April 1, 2008
Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure TrialAndrea M Russo, Jeanne E Poole, Daniel B Mark, et al.
Cancer Investigation|August 7, 2003
A phase I study of gemcitabine and docetaxel for advanced stage solid tumorsMichael E Poole, Stephen A Bernard, Mary Ann Churchel, et al.
BMJ (Clinical Research Ed.)|June 29, 1996
Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarctionJ K French, B F Williams, H H Hart, et al.
Journal of Cardiovascular Electrophysiology|January 1, 1997
Malignant sustained ventricular tachyarrhythmias in women: characteristics and outcome of treatment with an implantable cardioverter defibrillatorP J Kudenchuk, G H Bardy, J E Poole, et al.
Radiology|December 20, 2022
Radiographic Cortical Thickness Index Predicts Fragility Fracture in Gaucher DiseaseSimona D'Amore, Hiroshige Sano, Daniel David George Chappell, et al.
Heart Rhythm|July 19, 2021
Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysisKhaldoun G Tarakji, Panagiotis Korantzopoulos, Francois Philippon, et al.
Circulation|October 18, 2012
Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillatorRobert W Rho, Kristen K Patton, Jeanne E Poole, et al.
Journal of the American College of Cardiology|August 13, 2021
Increasing Participation of Women in Cardiovascular Trials: JACC Council PerspectivesLeslie Cho, Amanda R Vest, Michelle L O'Donoghue, et al.
Heart Rhythm O2|November 7, 2022
Risk factors for hematoma in patients undergoing cardiac device procedures: A WRAP-IT trial analysisKhaldoun G Tarakji, Panagiotis Korantzopoulos, Francois Philippon, et al.
American Heart Journal|June 2, 2007
Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Brian Olshansky, Freda Wood, Anne S Hellkamp, et al.
Pageof 31

Showing results (231-240 of 302) with videos related to

Sort By:
Pageof 31
Journal of Cardiovascular Electrophysiology|April 1, 2008
Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure TrialAndrea M Russo, Jeanne E Poole, Daniel B Mark, et al.
Cancer Investigation|August 7, 2003
A phase I study of gemcitabine and docetaxel for advanced stage solid tumorsMichael E Poole, Stephen A Bernard, Mary Ann Churchel, et al.
BMJ (Clinical Research Ed.)|June 29, 1996
Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarctionJ K French, B F Williams, H H Hart, et al.
Journal of Cardiovascular Electrophysiology|January 1, 1997
Malignant sustained ventricular tachyarrhythmias in women: characteristics and outcome of treatment with an implantable cardioverter defibrillatorP J Kudenchuk, G H Bardy, J E Poole, et al.
Radiology|December 20, 2022
Radiographic Cortical Thickness Index Predicts Fragility Fracture in Gaucher DiseaseSimona D'Amore, Hiroshige Sano, Daniel David George Chappell, et al.
Heart Rhythm|July 19, 2021
Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysisKhaldoun G Tarakji, Panagiotis Korantzopoulos, Francois Philippon, et al.
Circulation|October 18, 2012
Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillatorRobert W Rho, Kristen K Patton, Jeanne E Poole, et al.
Journal of the American College of Cardiology|August 13, 2021
Increasing Participation of Women in Cardiovascular Trials: JACC Council PerspectivesLeslie Cho, Amanda R Vest, Michelle L O'Donoghue, et al.
Heart Rhythm O2|November 7, 2022
Risk factors for hematoma in patients undergoing cardiac device procedures: A WRAP-IT trial analysisKhaldoun G Tarakji, Panagiotis Korantzopoulos, Francois Philippon, et al.
American Heart Journal|June 2, 2007
Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Brian Olshansky, Freda Wood, Anne S Hellkamp, et al.
Pageof 31